Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFMOROCTOCOG ALFA for Immune tolerance induction: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 46 adverse event reports in the FDA FAERS database where EFMOROCTOCOG ALFA was used for Immune tolerance induction.

Most Reported Side Effects for EFMOROCTOCOG ALFA

Side Effect Reports % Deaths Hosp.
Haemorrhage 836 45.6% 1 100
Traumatic haemorrhage 139 7.6% 0 28
Arthralgia 137 7.5% 1 23
Limb injury 120 6.6% 0 13
Fall 114 6.2% 1 26
Haemarthrosis 114 6.2% 0 11
Spontaneous haemorrhage 99 5.4% 0 13
Joint injury 97 5.3% 0 15
Contusion 73 4.0% 0 5
Head injury 67 3.7% 0 15
Pain 61 3.3% 0 15
Epistaxis 53 2.9% 0 6
Off label use 52 2.8% 0 4
Pain in extremity 49 2.7% 0 11
Weight increased 48 2.6% 0 16

Other Indications for EFMOROCTOCOG ALFA

Factor viii deficiency (832) Haemorrhage (219) Prophylaxis (61) Product used for unknown indication (46) Haemophilia (34) Haemorrhage prophylaxis (22) Haemarthrosis (10)

Other Drugs Used for Immune tolerance induction

RITUXIMAB (207) HUMAN IMMUNOGLOBULIN G (88) ASPIRIN (62) MYCOPHENOLATE MOFETIL (62) ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (53) --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (52) PHLEUM PRATENSE POLLEN (36) BORTEZOMIB (35) OXALIPLATIN (33) TACROLIMUS (33)

Related Pages

EFMOROCTOCOG ALFA Full Profile All Immune tolerance induction Drugs EFMOROCTOCOG ALFA Demographics EFMOROCTOCOG ALFA Timeline